Taken together, conjugating PD-L1 aptamer to albumin nanoparticle may prolong its circulation time in vivo, enhance tumor-targeting via the EPR effect, and increase targeting affinity by multivalent binding, resulting in improved antitumor efficacy. This evidence concerns the gene ALB and neoplasm.